SCHEMBL2704545

SCHEMBL2704545

CCCS(=O)(=O)c1ccccc1-c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 2/20 0.48
FEN1 P39748 2/20 0.48
CYP2C9 P11712 3/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2D6 P10635 2/20 0.46
PTGS2 P35354 1/20 0.43
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
PSIP1 O75475 1/20 0.41
CYP2C19 P33261 2/20 0.40
CYP1A2 P05177 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
ADRA2C P18825 2/20 0.40
ADRA1D P25100 2/20 0.40
ADRA1A P35348 2/20 0.40
ADRA1B P35368 2/20 0.40
AKR1B1 P15121 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2445897 0.95 ALOX5AP (0.47) ALOX5APFEN1CYP2C9CYP3A4CYP2D6
SCHEMBL2703944 0.89 ALOX5AP (0.46) ALOX5APFEN1CYP2C9CYP3A4CYP2D6
SCHEMBL4629540 0.88 ALOX5AP (0.50) ALOX5APFEN1HPGDEDNRBEDNRA
SCHEMBL2704655 0.86 PSIP1 (0.50) ALOX5APFEN1CYP2C9CYP3A4CYP2D6
SCHEMBL4629650 0.86 ALOX5AP (0.52) ALOX5APFEN1
SCHEMBL9813813 0.86 PTGS2 (0.50) ALOX5APFEN1CYP2C9CYP3A4CYP2D6
SCHEMBL2449150 0.81 PTGS2 (0.50) ALOX5APFEN1CYP2C9CYP3A4CYP2D6
SCHEMBL7208440 0.80 CA2 (0.44) ALOX5APFEN1PTGS2KDM4EALDH1A1
SCHEMBL7212096 0.79 MMP8 (0.47) ALOX5APFEN1PTGS2KDM4EALDH1A1
SCHEMBL29386971 0.78 KDM4E (0.43) ALOX5APFEN1PTGS2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2287162-B1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders OTSUKA PHARMA CO LTD (JP) 2012-05-09 EP disclosed
EP-1919907-A2 HETEROCYCLIC COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-05-14 EP disclosed
WO-2007026959-A2 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 WO disclosed
EP-0939628-A4 THIOL SULFONE METALLOPROTEASE INHIBITORS MONSANTO CO (US) 1999-12-22 EP disclosed
EP-0939628-A1 THIOL SULFONE METALLOPROTEASE INHIBITORS MONSANTO COMPANY (US) 1999-09-08 EP disclosed
WO-1998003164-A1 THIOL SULFONE METALLOPROTEASE INHIBITORS MONSANTO COMPANY (US) 1998-01-29 WO disclosed